Volume 19, Number 12—December 2013
Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009
|Reporting source||Total confirmed/probable GBS case-patientss||A(H1N1)pdm09 monovalent vaccine status
|Received, no. (%)||Did not receive, no. (%)|
|Clinical Network† and SPARCS‡||140||19 (14)||121 (86)|
|SPARCS||130||19 (15)||111 (85)|
|Clinical Network||91||13 (14)||78 (86)|
|SPARCS-only¶||49||6 (12)||43 (88)|
*GBS, Guillain-Barré syndrome; SPARCS, Statewide Planning and Research Cooperative System.
†Network of >2,494 reporting clinical neurologists.
‡SPARCS refers to all suspected cases identified through hospital discharge data (some of these cases might have been identified by the Clinical Network as well).
¶Cases missed by the Clinical Network and identified only through SPARCS.
1Current affiliation: Weill Cornell Medical College, New York, New York, USA.
- Page created: November 19, 2013
- Page last updated: November 19, 2013
- Page last reviewed: November 19, 2013
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)